Latest News

news

Artiria Medical has reached a significant milestone with the successful completion of 100 cases in North America

Excellent clinical results and adoption of SmartGUIDE 014 with the support of our amazing North American partners

July 10, 2025

press release

Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the US following promising first in-human results and FDA clearance

Artiria Medical is ready to initiate clinical studies using SmartGUIDE in Europe (premarket) and the US (postmarket) following promising first in-human results and FDA clearance

February 27, 2024

press release

Artiria receives FDA 510(k) clearance for Disruptive Deflectable Guidewire

Artiria Medical, a Swiss neurovascular MedTech company, announces that its real-time deflectable guidewire has been granted the 510(k) clearance by the U.S. Food and Drug Administration (FDA).

May 26, 2023

press release

Artiria raised CHF 3.8 M to improve stroke treatments

Artiria Medical raised CHF 3.8 M, including a CHF 2.7 M grant from the highly selective EIC accelerator program and a CHF 1.1 M bridge financing.

April 30, 2022